SLDB — Solid Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Solid Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	208	214	124	149	188
Net Total Accounts Receivable
Net Total Receivables	0.11	0	—	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	223	220	130	157	205
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.6	38.6	33.2	29	26.1
Other Long Term Assets
Total Assets	232	260	165	189	233
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	23.6	22.5	14.5	30.3	33.5
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	24.2	48.6	38.5	51.4	52.5
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	208	212	126	137	180
Total Liabilities & Shareholders' Equity	232	260	165	189	233
Total Common Shares Outstanding